MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 140 filers reported holding MERSANA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $72,318 | -87.3% | 56,943 | -67.2% | 0.00% | – |
Q2 2023 | $571,199 | -25.0% | 173,617 | -6.4% | 0.00% | – |
Q1 2023 | $761,990 | -54.9% | 185,399 | -35.8% | 0.00% | -100.0% |
Q4 2022 | $1,691,213 | +850.1% | 288,603 | +997.6% | 0.00% | – |
Q3 2022 | $178,000 | +334.1% | 26,295 | +197.8% | 0.00% | – |
Q2 2022 | $41,000 | -31.7% | 8,829 | -41.6% | 0.00% | – |
Q1 2022 | $60,000 | -94.7% | 15,124 | -91.7% | 0.00% | – |
Q4 2021 | $1,127,000 | +35.5% | 181,163 | +105.3% | 0.00% | – |
Q3 2021 | $832,000 | +161.6% | 88,231 | +276.5% | 0.00% | – |
Q2 2021 | $318,000 | -77.4% | 23,436 | -73.1% | 0.00% | – |
Q1 2021 | $1,409,000 | +733.7% | 87,081 | +1270.3% | 0.00% | – |
Q4 2020 | $169,000 | +207.3% | 6,355 | +115.3% | 0.00% | – |
Q3 2020 | $55,000 | -11.3% | 2,952 | +10.6% | 0.00% | – |
Q2 2020 | $62,000 | -57.5% | 2,669 | -89.4% | 0.00% | – |
Q1 2020 | $146,000 | -44.1% | 25,096 | -44.8% | 0.00% | – |
Q4 2019 | $261,000 | +480.0% | 45,464 | +59.5% | 0.00% | – |
Q3 2019 | $45,000 | +50.0% | 28,512 | +280.2% | 0.00% | – |
Q2 2019 | $30,000 | +275.0% | 7,499 | +397.0% | 0.00% | – |
Q1 2019 | $8,000 | -73.3% | 1,509 | -79.4% | 0.00% | – |
Q4 2018 | $30,000 | -9.1% | 7,311 | +119.4% | 0.00% | – |
Q3 2018 | $33,000 | 0.0% | 3,333 | +81.3% | 0.00% | – |
Q2 2018 | $33,000 | +26.9% | 1,838 | +12.7% | 0.00% | – |
Q1 2018 | $26,000 | +23.8% | 1,631 | +26.8% | 0.00% | – |
Q4 2017 | $21,000 | -25.0% | 1,286 | -19.1% | 0.00% | – |
Q3 2017 | $28,000 | +16.7% | 1,590 | -5.6% | 0.00% | – |
Q2 2017 | $24,000 | – | 1,685 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |